Cargando…

Analysis of survival data in thalassemia patients in Shiraz, Iran

OBJECTIVES: The survival rate of thalassemia patients has not been conclusively established, and the factors associated with survival remain unclear. This study aimed to determine the survival rate of thalassemia among patients in southern Iran and to identify the factors associated with mortality f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajaeefard, Abdolreza, Hajipour, Mahmoud, Tabatabaee, Hamid Reza, Hassanzadeh, Jafar, Rezaeian, Shahab, Moradi, Zahra, Sharafi, Mehdi, Shafiee, Mohsen, Semati, Ali, Safaei, Sanaz, Soltani, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Epidemiology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616013/
https://www.ncbi.nlm.nih.gov/pubmed/26212506
http://dx.doi.org/10.4178/epih/e2015031
_version_ 1782396548043243520
author Rajaeefard, Abdolreza
Hajipour, Mahmoud
Tabatabaee, Hamid Reza
Hassanzadeh, Jafar
Rezaeian, Shahab
Moradi, Zahra
Sharafi, Mehdi
Shafiee, Mohsen
Semati, Ali
Safaei, Sanaz
Soltani, Maryam
author_facet Rajaeefard, Abdolreza
Hajipour, Mahmoud
Tabatabaee, Hamid Reza
Hassanzadeh, Jafar
Rezaeian, Shahab
Moradi, Zahra
Sharafi, Mehdi
Shafiee, Mohsen
Semati, Ali
Safaei, Sanaz
Soltani, Maryam
author_sort Rajaeefard, Abdolreza
collection PubMed
description OBJECTIVES: The survival rate of thalassemia patients has not been conclusively established, and the factors associated with survival remain unclear. This study aimed to determine the survival rate of thalassemia among patients in southern Iran and to identify the factors associated with mortality from thalassemia. METHODS: This retrospective cohort study was conducted based on a retrospective review of the medical records of 911 beta-thalassemia patients in 2014. Data analysis was conducted using the Kaplan-Meier method and Cox regression analysis. RESULTS: Overall, 212 patients (23.3%) died, and 26.8% had thalassemia intermedia. The 20-year, 40-year, and 60-year survival rates were 85%, 63%, and 54%, respectively. Both crude and adjusted analyses found that education, marital status, ferritin levels, and comorbidities were related to mortality. CONCLUSIONS: Sociodemographic and hematological factors were found to be significantly associated with the survival rate of thalassemia. Addressing these factors may help healthcare providers and physicians to provide the best possible care and to improve the survival rate.
format Online
Article
Text
id pubmed-4616013
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Korean Society of Epidemiology
record_format MEDLINE/PubMed
spelling pubmed-46160132015-10-23 Analysis of survival data in thalassemia patients in Shiraz, Iran Rajaeefard, Abdolreza Hajipour, Mahmoud Tabatabaee, Hamid Reza Hassanzadeh, Jafar Rezaeian, Shahab Moradi, Zahra Sharafi, Mehdi Shafiee, Mohsen Semati, Ali Safaei, Sanaz Soltani, Maryam Epidemiol Health Original Article OBJECTIVES: The survival rate of thalassemia patients has not been conclusively established, and the factors associated with survival remain unclear. This study aimed to determine the survival rate of thalassemia among patients in southern Iran and to identify the factors associated with mortality from thalassemia. METHODS: This retrospective cohort study was conducted based on a retrospective review of the medical records of 911 beta-thalassemia patients in 2014. Data analysis was conducted using the Kaplan-Meier method and Cox regression analysis. RESULTS: Overall, 212 patients (23.3%) died, and 26.8% had thalassemia intermedia. The 20-year, 40-year, and 60-year survival rates were 85%, 63%, and 54%, respectively. Both crude and adjusted analyses found that education, marital status, ferritin levels, and comorbidities were related to mortality. CONCLUSIONS: Sociodemographic and hematological factors were found to be significantly associated with the survival rate of thalassemia. Addressing these factors may help healthcare providers and physicians to provide the best possible care and to improve the survival rate. Korean Society of Epidemiology 2015-07-07 /pmc/articles/PMC4616013/ /pubmed/26212506 http://dx.doi.org/10.4178/epih/e2015031 Text en ©2015, Korean Society of Epidemiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rajaeefard, Abdolreza
Hajipour, Mahmoud
Tabatabaee, Hamid Reza
Hassanzadeh, Jafar
Rezaeian, Shahab
Moradi, Zahra
Sharafi, Mehdi
Shafiee, Mohsen
Semati, Ali
Safaei, Sanaz
Soltani, Maryam
Analysis of survival data in thalassemia patients in Shiraz, Iran
title Analysis of survival data in thalassemia patients in Shiraz, Iran
title_full Analysis of survival data in thalassemia patients in Shiraz, Iran
title_fullStr Analysis of survival data in thalassemia patients in Shiraz, Iran
title_full_unstemmed Analysis of survival data in thalassemia patients in Shiraz, Iran
title_short Analysis of survival data in thalassemia patients in Shiraz, Iran
title_sort analysis of survival data in thalassemia patients in shiraz, iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616013/
https://www.ncbi.nlm.nih.gov/pubmed/26212506
http://dx.doi.org/10.4178/epih/e2015031
work_keys_str_mv AT rajaeefardabdolreza analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT hajipourmahmoud analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT tabatabaeehamidreza analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT hassanzadehjafar analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT rezaeianshahab analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT moradizahra analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT sharafimehdi analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT shafieemohsen analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT sematiali analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT safaeisanaz analysisofsurvivaldatainthalassemiapatientsinshiraziran
AT soltanimaryam analysisofsurvivaldatainthalassemiapatientsinshiraziran